These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4307060)

  • 1. [Toxin formation by Cl. perfringens type E].
    Zemlianitskaia EP; Matveev KI; Tsurikov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective properties of theta-hemolysin obtained by affinity chromatography].
    Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxin production by Cl. perfringens of types A and D on synthetic media].
    Bychenko BD; Ivanova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):84-9. PubMed ID: 4298565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of experimental Clostridium novyi and Cl. perfringens gas gangrene in high-velocity missile wounds by active immunisation.
    Boyd NA; Thomson RO; Walker PD
    J Med Microbiol; 1972 Nov; 5(4):467-72. PubMed ID: 4345766
    [No Abstract]   [Full Text] [Related]  

  • 9. [The experimental validation of methods for the emergency immunoprophylaxis of gas gangrene].
    Sergeeva TI; Chirikova EV; Babaĭtseva VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):9-13. PubMed ID: 8525744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental gas gangrene with food-poisoning Clostridium perfringens type A.
    Hauschild AH; Thatcher FS
    Can J Microbiol; 1968 Jun; 14(6):705-9. PubMed ID: 4298928
    [No Abstract]   [Full Text] [Related]  

  • 11. [An electron microscopic study of Cl. perfringens in the process of toxin formation].
    Kushnarev VM; Smirnova TA; Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):19-24. PubMed ID: 4308710
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
    Ito A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
    [No Abstract]   [Full Text] [Related]  

  • 14. [The functional activity of wound mononuclear phagocytosing cells in revaccination with a Clostridium perfringens anatoxin].
    Sergeeva TI; Zaĭtseva LG; Chirikova EV; Vasil'eva EI; Babaĭtseva VA; Kornienko OIu
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):63-5. PubMed ID: 7879544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of Cl. perfringens types A, B, C, D, E and F in the etiology of gas gangrene].
    Marasanova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Aug; 48(8):116-21. PubMed ID: 4329186
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of peptidic groups isolated from enzymic casein hydrolysate on growth and toxinogenesis of Clostridium welchii (perfringens).
    Nekvasilová K; Sídlo J; Háza J
    J Gen Microbiol; 1970 Jul; 62(1):3-16. PubMed ID: 4321096
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of zinc on the production of various toxins of Clostridium perfringens.
    Murata R; Soda S; Yamamoto A; Sato H; Ito A
    Jpn J Med Sci Biol; 1969 Jun; 22(3):133-48. PubMed ID: 4310348
    [No Abstract]   [Full Text] [Related]  

  • 18. [Method of determinating the protective capacity of C1. perfringens toxoid].
    Akhundova KA; Nenashev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):43-7. PubMed ID: 176851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
    Vlasova EV; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):113-6. PubMed ID: 4315881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphologic and some histochemical changes in the organism of immune guinea pigs during intramuscular injection of Cl. sordelli toxin].
    Ermakova MP; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):105-9. PubMed ID: 5561295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.